pharmaceuticals
NIH funds research into infant opioid withdrawal syndrome treatment
October 3, 2017Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals
As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …
Makers of immediate-release opioids must fund training on their use, FDA says
September 29, 2017Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin
As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …
EMA relocation will cause drug approval delays even in best case scenario, agency says
September 27, 2017Research and Development EMA, brexit, pharma, pharmaceuticals
As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …
Refining the system: Improving patients’ access to medicine
September 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals
The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …
Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab
September 19, 2017Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion
September 18, 2017Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals
Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …
Novartis exec designated as new CEO after Jimenez announces retirement
September 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …
Merck KGaA commits to continued partnership with Ugandan Government
September 5, 2017Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …
Novartis celebrates success of Gilenya in paediatric multiple sclerosis
September 5, 2017Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals
Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …
Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds
September 5, 2017Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol
A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …
Takeda partners up to develop “next generation” CAR T solid tumour therapy
September 4, 2017Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals
Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …
Novartis CEO Jimenez announces retirement in 2018
September 4, 2017Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …
Has Trump’s power over pharma come to an end after Charlottesville?
August 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president
In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Teva scores expanded indication for Austedo in tardive dyskinesia
August 31, 2017Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals
Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …
Immunotherapy firm develops breakthrough method for robust bispecific antibody production
August 30, 2017Research and Development antibodies, immunotherapy, merus, pharma, pharmaceuticals
A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
